Semi-synthetic ajmaline derivative. Prepn from ajmaline: BE 622395 (1962 to Inverni Della Beffa), C.A. 59, 8816d (1963); A. Bonati, A. Bocchia, Farmaco Ed. Sci. 18, 84 (1963). Improved prepn: A. Bonati, DE 2023949; eidem, US 3741972 (1970, 1973 both to Inverni Della Beffa). In vitro and in vivo anti-arrhythmic activity: C. Capra, Farmaco Ed. Sci. 19, 865 (1964); cardiac action: Y. Katano et al., Arzneim.-Forsch. 23, 483 (1973); cardiovascular effects and toxicity: C. Capra et al., Farmaco Ed. Prat. 35, 49 (1980). Determination in plasma by TLC fluorescence: L. J. Dombrowski et al., J. Pharm. Sci. 64, 643 (1975). GC-MS determination in blood: St. D. Clemans et al., Arzneim.-Forsch. 27, 1128 (1977). Comparison with other ajmaline esters: M. Salmona et al., J. Pharm. Sci. 64, 1561 (1975); P. Jaillon et al., Arch. Int. Pharmacodyn. 224, 310 (1976). Clinical studies: M. Cafiero et al., Minerva Cardioangiol. 32, 59 (1984). Book: G. G. Gensini, Ed., Concepts on the Mechanism and Treatment of Arrhythmias (Futura Publishing Co., Mount Kisco, N.Y., 1974) 281 pp.
Antiarrhythmic (cardiac depressant).
Antiarrhythmic